4//SEC Filing
COLLAGENEX PHARMACEUTICALS INC 4
Accession 0001179110-08-001537
CIK 0001012270operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 9:16 AM ET
Size
9.1 KB
Accession
0001179110-08-001537
Insider Transaction Report
Form 4
PFEIFFER DAVID F
Sr. VP, Sales and Marketing
Transactions
- Exercise/Conversion
Option to purchase common stock
2008-01-22−6,666→ 302,834 totalExercise: $6.25Exp: 2008-02-12→ Common Stock (6,666 underlying) - Sale
Common Stock
2008-01-22$10.88/sh−6,666$72,527→ 11,500 total - Exercise/Conversion
Common Stock
2008-01-22$6.25/sh+6,666$41,663→ 18,166 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2007.
- [F2]Represents partial exercise of an option to purchase an aggregate of 20,000 shares granted by the Issuer pursuant to its 1996 Stock Option Plan on February 12, 1998. Such option vested as follows: 4,000 shares subject to such option vested on February 12, 1999, 4,000 shares subject to such option vested on February 12, 2000, 4,000 shares subject to such option vested on February 12, 2001, 4,000 shares subject to such option vested on February 12, 2002 and 4,000 shares subject to such option vested on February 12, 2003.
- [F3]Includes multiple option grants with different prices and vesting dates.
Documents
Issuer
COLLAGENEX PHARMACEUTICALS INC
CIK 0001012270
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012270
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 9:16 AM ET
- Size
- 9.1 KB